[ Price : $8.95]
GE HealthCare subsidiary Datex-Ohmeda recalls its Giraffe OmniBed and Giraffe OmniBed CareStation to update their use instructions...[ Price : $8.95]
UCB says its investigational Alzheimers drug bepranemab missed the primary endpoint in a Phase 2a trial but hit secondary endpoint...[ Price : $8.95]
Verastem Oncology completes a rolling NDA submission for the combination of avutometinib and defactinib for adults with recurrent ...[ Price : $8.95]
FDA publishes the International Council for Harmonization M13A guidance on bioequivalence studies for immediate-release solid oral...[ Price : $8.95]
Sage Therapeutics and Biogen decide to not seek an expanded use (major depressive disorder) for postpartum depression drug Zurzuva...[ Price : $8.95]
Rep. Abigail Spanberger asks FDA and DEA for additional information on their efforts to address shortages of ADHD drugs.[ Price : $8.95]
FDA posts the establishment inspection report with seven observations from a 2023 inspection at a Boehringer Ingelheim drug manufa...[ Price : $8.95]
FDA approves the removal of an imaging contraindication on Abbotts FreeStyle Libre 2 and 3 continuous glucose monitoring systems.